PHI 24/18 Private Health Insurance (Benefit Requirements) Amendment Rules 2018 (No.2)

Page last updated: 30 April 2018

PHI 24/18 Private Health Insurance (Benefit Requirements) Amendment Rules 2018 (No.2) (PDF 49 KB)

RECENT AMENDMENTS

The Private Health Insurance (Benefit Requirements) Amendment Rules 2018 (No.2) (the Amendment Rules) were registered with the Federal Register of Legislation (FRL) and commence on 1 May 2018. These Amendment Rules amend the Private Health Insurance (Benefit Requirements) Rules 2011 (the Principal Rules).

SUMMARY OF CHANGES

Schedule 3, Part 2 Type B Procedures, Clause 5 Non-band specific Type B day procedures, Subclause 1
Item 1 amends Schedule 3, Part 2 Type B Procedures, Clause 5 Non-band specific Type B day procedures, Subclause 1 of the Principal Rules by inserting two new MBS items (38288, 42652). 38288 is a new MBS item for diagnosis of atrial fibrillation in patients with cryptogenic stroke using an implantable loop recorder. 42652 is a new ophthalmology MBS item for the treatment of progressive corneal ectatic disease.

Item 2 - Schedule 3, Part 3 – Type C Procedures, Clause 8 Interpretation, Category 2 Diagnostic procedures and investigations, Subclause D1
Item 2 amends Schedule 3, Part 3 – Type C procedures, Clause 8 Interpretation, Category 2 Diagnostic procedures and investigations, Subclause D1of the Principal Rules by inserting one new MBS item (11728). 11728 is a new MBS item for diagnosis of atrial fibrillation in patients with cryptogenic stroke using an implantable loop recorder.

Item 3 - Schedule 3, Part 3 – Type C Procedures, Clause 8 Interpretation, Category 3 Therapeutic Procedures, Subclause T8
Item 3 amends Schedule 3, Part 3 – Type C procedures, Clause 8 Interpretation, Category 3 Therapeutic Procedures, Subclause T8 of the Principal Rules by inserting two new MBS items (32528, 32529). 32528 and 32529 are new MBS items for the treatment of varicose veins caused by chronic venous insufficiency.

Item 4 - Schedule 3, Part 3 – Type C Procedures, Clause 8 Interpretation, Category 5 Diagnostic Imaging Services, Subclause I4
Item 4 amends Schedule 3, Part 3 – Type C Procedures, Clause 8 Interpretation, Category 5 Diagnostic Imaging Services, Subclause I4 of the Principal Rules by inserting one new MBS item (61647). 61647 is a new MBS item for whole body Positron Emission Tomography using 68Gallium DOTA peptide for diagnosis of gastoenteropancreatic neuroendocrine tumour.

Item 5 - Schedule 3, Part 3 – Type C Procedures, Clause 8 Interpretation, Category 5 Diagnostic Imaging Services, Subclause I5
Item 5 amends Schedule 3, Part 3 – Type C Procedures, Clause 8 Interpretation, Category 5 Diagnostic Imaging Services, Subclause I5 of the Principal Rules by inserting six new MBS items (63395, 63396, 63397, 63398, 63547, and 63548). The four new MBS items (63395, 63396, 63397, 63398) are for Magnetic Resonance Imaging (MRI) of the cardiovascular system for the diagnosis of Arrthymogenic Right Ventricular Cardiomyopathy, and the two new MBS items (63547, 63548) are for MRI services for Breast Implant-Associated Anaplastic Large Cell Lymphoma.